Metabolic effects of orally administered small-molecule agonists of GPR55 and GPR119 in multiple low-dose streptozotocin-induced diabetic and incretin-receptor-knockout mice

G protein-coupled receptors: signalling and regulation by lipid agonists for improved glucose homoeostasis

(2016) Brian M. Moran et al.   ACTA DIABETOLOGICA

GPR119 Agonist AS1269574 Activates TRPA1 Cation Channels to Stimulate GLP-1 Secretion

(2016) Oleg G. Chepurny et al.   MOLECULAR ENDOCRINOLOGY

GPR39 receptors and actions of trace metals on pancreatic beta cell function and glucose homoeostasis

(2015) Brian. M. Moran et al.   ACTA DIABETOLOGICA

Deletion of G-protein-coupled receptor 55 promotes obesity by reducing physical activity

(2015) A Meadows et al.   INTERNATIONAL JOURNAL OF OBESITY

GPR55: From orphan to metabolic regulator?

(2015) Bo Liu et al.   PHARMACOLOGY & THERAPEUTICS

Physiology of Proglucagon Peptides: Role of Glucagon and GLP-1 in Health and Disease

(2015) Darleen A. Sandoval et al.   PHYSIOLOGICAL REVIEWS

Activation of GPR119 by fatty acid agonists augments insulin release from clonal β-cells and isolated pancreatic islets and improves glucose tolerance in mice

(2013) Brian M. Moran et al.   BIOLOGICAL CHEMISTRY

Glucose-dependent insulinotropic polypeptide (GIP) receptor deletion leads to reduced bone strength and quality

(2013) Aleksandra Mieczkowska et al.   BONE

Evaluation of the insulin releasing and antihyperglycaemic activities of GPR55 lipid agonists using clonal beta-cells, isolated pancreatic islets and mice

(2013) A M McKillop et al.   BRITISH JOURNAL OF PHARMACOLOGY

Free Fatty Acids-Sensing G Protein-Coupled Receptors in Drug Targeting and Therapeutics

(2013) Tomo Yonezawa et al.   CURRENT MEDICINAL CHEMISTRY

Optimal bone mechanical and material properties require a functional glucagon-like peptide-1 receptor

(2013) Guillaume Mabilleau et al.   JOURNAL OF ENDOCRINOLOGY

Stimulation of Proglucagon Gene Expression by Human GPR119 in Enteroendocrine L-cell Line GLUTag

(2013) Oleg G. Chepurny et al.   MOLECULAR ENDOCRINOLOGY

Stimulating β-Cell Regeneration by Combining a GPR119 Agonist with a DPP-IV Inhibitor

(2013) Ansarullah et al.   PLoS One

High-Throughput Screening for GPR119 Modulators Identifies a Novel Compound with Anti-Diabetic Efficacy in db/db Mice

(2013) Meng Zhang et al.   PLoS One

The L- -Lysophosphatidylinositol/GPR55 System and Its Potential Role in Human Obesity

(2011) J. M. Moreno-Navarrete et al.   DIABETES

Incretin Effects on  -Cell Function, Replication, and Mass: The human perspective

(2011) A. J. Garber   DIABETES CARE

A role for the putative cannabinoid receptor GPR55 in the islets of Langerhans

(2011) Silvana Y Romero-Zerbo et al.   JOURNAL OF ENDOCRINOLOGY

Ranolazine Increases  -Cell Survival and Improves Glucose Homeostasis in Low-Dose Streptozotocin-Induced Diabetes in Mice

(2011) Y. Ning et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

A novel CB receptor GPR55 and its ligands are involved in regulation of gut movement in rodents

(2011) X.-H. Lin et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Stimulating beta cell replication and improving islet graft function by GPR119 agonists

(2011) Jie Gao et al.   TRANSPLANT INTERNATIONAL

AS1907417, a novel GPR119 agonist, as an insulinotropic and β-cell preservative agent for the treatment of type 2 diabetes

(2010) Shigeru Yoshida et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Identification of a novel GPR119 agonist, AS1269574, with in vitro and in vivo glucose-stimulated insulin secretion

(2010) Shigeru Yoshida et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Animal research: Reporting in vivo experiments: The ARRIVE guidelines

(2010) Carol Kilkenny et al.   BRITISH JOURNAL OF PHARMACOLOGY

GPR119 Regulates Murine Glucose Homeostasis Through Incretin Receptor-Dependent and Independent Mechanisms

(2010) Grace Flock et al.   ENDOCRINOLOGY

Review: Hydroxyoctadecadienoic acids: novel regulators of macrophage differentiation and atherogenesis

(2010) Venkat Vangaveti et al.   Therapeutic Advances in Endocrinology and Metabolism

GPR119 Is Essential for Oleoylethanolamide-Induced Glucagon-Like Peptide-1 Secretion From the Intestinal Enteroendocrine L-Cell

(2009) L. M. Lauffer et al.   DIABETES

Atypical Responsiveness of the Orphan Receptor GPR55 to Cannabinoid Ligands

(2009) Ankur Kapur et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo

(2009) L. S. Whyte et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Receptors for acylethanolamides—GPR55 and GPR119

(2009) Grzegorz Godlewski et al.   PROSTAGLANDINS & OTHER LIPID MEDIATORS

A Role for Intestinal Endocrine Cell-Expressed G Protein-Coupled Receptor 119 in Glycemic Control by Enhancing Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Peptide Release

(2008) Zhi-Liang Chu et al.   ENDOCRINOLOGY

The putative cannabinoid receptor GPR55 plays a role in mechanical hyperalgesia associated with inflammatory and neuropathic pain

(2008) Penny C. Staton et al.   PAIN